Nezefib (Dexamethasone Sodium Phosphate, Chloramphenicol)

Dexamethasone sodium phosphate, the active ingredient in Nezefib, is a corticosteroid presented as a sterile ophthalmic solution for ocular use. Combined with chloramphenicol, it treats inflammatory eye conditions and bacterial infections, providing both anti‑inflammatory and broad‑spectrum antibacterial effects for patients requiring postoperative or therapeutic eye care.

GNH USA supplies Nezefib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from regulatory compliance, batch traceability, and responsive technical support.

Nezefib is indicated for ocular conditions where inflammation and bacterial infection coexist, addressing both pathways.

- Ocular inflammation: reduces swelling, pain and cellular infiltrate in conditions such as uveitis or postoperative inflammation. - Bacterial conjunctivitis: eliminates susceptible bacteria, relieving redness, discharge and discomfort. - Pre‑ and post‑operative eye surgery prophylaxis: prevents infection and controls inflammation before and after ophthalmic procedures.

Nezefib may cause ocular and systemic adverse reactions; they are categorized by frequency and severity.

Common Side Effects: - Eye irritation or burning sensation. - Transient blurred vision. - Mild increase in intra‑ocular pressure. - Local allergic conjunctivitis.

Serious or Rare Side Effects: - Secondary ocular infection or worsening of existing infection. - Development of cataract with prolonged use. - Glaucoma due to sustained intra‑ocular pressure rise. - Severe allergic reaction including anaphylaxis.

When prescribing Nezefib, clinicians should consider several safety measures. - Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: unknown excretion; consider risk‑benefit before prescribing. - Pre‑existing glaucoma: monitor intra‑ocular pressure closely. - Concurrent ocular infection: assess need for additional antimicrobial coverage. - Use in children: limit duration and follow specialist guidance. - Store at room temperature: keep in original container, protect from light and moisture.

Nezefib can interact with other medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Systemic corticosteroids: may increase systemic steroid exposure. - Systemic chloramphenicol: risk of additive bone‑marrow suppression. - Topical non‑steroidal anti‑inflammatory eye drops: heightened risk of corneal melting. - Anticholinergic ophthalmic agents: may reduce drug absorption.

Moderate Interactions (Monitor Closely): - Other topical steroids: cumulative steroid effect on intra‑ocular pressure. - Antiviral eye drops: possible reduced antiviral efficacy. - Glaucoma medications: monitor pressure when used together.